Cancer Stem Cell

The Cancer Stem Cell Program is determining whether cancer stem cells are clinically relevant by expanding the knowledge of tumour-initiating cells in several types of cancer, characterizing cancer stem cells and translating their properties into improved tools for clinicians and therapeutics for patients. It has already established that cancer stem cells are clinically relavant across at least four different tumour types: head and neck, breast and musculoskeletal cancer, and leukemia.